search button
Open Access

Use of β‑blockers and risk of age‑related macular degeneration among hypertensive patients: An insight from The National Health and Nutrition Examination Survey

  • Authors:
    • Yili Luo
    • Jianpeng Liu
    • Wangqiang Feng
    • Da Lin
    • Guangwei Song
    • Mengji Chen
    • Haihua Zheng

  • View Affiliations

  • Published online on: January 30, 2023     https://doi.org/10.3892/mi.2023.70
  • Article Number: 10

  • Copyright : © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although age‑related macular degeneration (AMD) is the leading cause of legal blindness, the treatment methods for AMD are limited. The aim of the present study was to examine the association between oral β‑blockers (BBs) and the risk of developing AMD among hypertensive patients. For this purpose, a total of 3,311 hypertensive patients from the National Health and Nutrition Examination Survey were included in the study. The use of BBs and treatment duration data were collected using a self‑reported questionnaire. AMD was diagnosed by gradable retinal images. Multivariate‑adjusted survey‑weighted univariate logistic regression was used to confirm the association between the use of BBs and the risk of developing AMD. The results revealed that the use of BBs exerted a beneficial effect (odds ratio (OR), 0.34; 95% confidence interval (95% CI, 0.13‑0.92; P=0.04) in late‑stage AMD in the multivariate adjusted model. When the BBs were classified into non‑selective BBs and selective BBs, the protective effect in late‑stage AMD was still observed in the non‑selective BBs (OR, 0.20; 95% CI, 0.07‑0.61; P<0.001). After accounting for treatment duration, long‑term treatment with BBs (>6 years) was also found to reduce the risk of late‑stage AMD (OR, 0.13; 95% CI, 0.03‑0.63; P=0.01). In late‑stage AMD, the long‑term use of BBs was beneficial for geographic atrophy (OR, 0.07; 95% CI, 0.02‑0.28; P<0.001). On the whole, the present study demonstrates that the use of non‑selective BBs exerted a beneficial effect against the risk of late‑stage AMD among hypertensive patients. Long‑term treatment with BBs was also associated with lower risk of developing AMD. These findings may provide novel strategies for the management and treatment of AMD.
View Figures
View References

Related Articles

Journal Cover

January-February 2023
Volume 3 Issue 1

Print ISSN: 2754-3242
Online ISSN:2754-1304

Sign up for eToc alerts

Recommend to Library

International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Luo Y, Liu J, Feng W, Lin D, Song G, Chen M and Zheng H: Use of β‑blockers and risk of age‑related macular degeneration among hypertensive patients: An insight from The National Health and Nutrition Examination Survey. Med Int 3: 10, 2023
APA
Luo, Y., Liu, J., Feng, W., Lin, D., Song, G., Chen, M., & Zheng, H. (2023). Use of β‑blockers and risk of age‑related macular degeneration among hypertensive patients: An insight from The National Health and Nutrition Examination Survey. Medicine International, 3, 10. https://doi.org/10.3892/mi.2023.70
MLA
Luo, Y., Liu, J., Feng, W., Lin, D., Song, G., Chen, M., Zheng, H."Use of β‑blockers and risk of age‑related macular degeneration among hypertensive patients: An insight from The National Health and Nutrition Examination Survey". Medicine International 3.1 (2023): 10.
Chicago
Luo, Y., Liu, J., Feng, W., Lin, D., Song, G., Chen, M., Zheng, H."Use of β‑blockers and risk of age‑related macular degeneration among hypertensive patients: An insight from The National Health and Nutrition Examination Survey". Medicine International 3, no. 1 (2023): 10. https://doi.org/10.3892/mi.2023.70